Martina Ferrillo

Dr. Martina Ferrillo

Department of Health Sciences, University Magna Graecia di Catanzaro, 88100 Catanzaro, Italy
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
Alessandro de SireAlessandro de Sire
Alessandro de Sire
Martina FerrilloMartina Ferrillo
Martina Ferrillo
Lorenzo LippiLorenzo Lippi
Lorenzo Lippi
FAFrancesco Agostini
Francesco Agostini
RSRoberto De Sire
Roberto De Sire
MMMario Migliario
Mario Migliario
Frailty is a highly prevalent condition in the elderly that has been increasingly considered as a crucial public health issue, due to the strict correlation with a higher risk of fragility fractures, hospitalization, and mortality. Among the age-related diseases, sarcopenia and dysphagia are two common pathological conditions in frail older people and could coexist leading to dehydration and malnutrition in these subjects. “Sarcopenic dysphagia” is a complex condition characterized by deglutition impairment due to the loss of mass and strength of swallowing muscles and might be also related to poor oral health status. Moreover, the aging process is strictly related to poor oral health status due to direct impairment of the immune system and wound healing and physical and cognitive impairment might indirectly influence older people’s ability to carry out adequate oral hygiene. Therefore, poor oral health might affect nutrient intake, leading to malnutrition and, consequently, to frailty. In this scenario, sarcopenia, dysphagia, and oral health are closely linked sharing common pathophysiological pathways, disabling sequelae, and frailty. Thus, the aim of the present comprehensive review is to describe the correlation among sarcopenic dysphagia, malnutrition, and oral frailty, characterizing their phenotypically overlapping features, to propose a comprehensive and effective management of elderly frail subjects.

Verified
Journal Article
Open access
PDF file
Martina FerrilloMartina Ferrillo
Martina Ferrillo
Amerigo GiudiceAmerigo Giudice
Amerigo Giudice
Nicola MarottaNicola Marotta
Nicola Marotta
FFFrancesco Fortunato
Francesco Fortunato
DVDaniela Di Venere
Daniela Di Venere
Alessandro de SireAlessandro de Sire
Alessandro de Sire
Temporomandibular disorders (TMD) are a group of musculoskeletal diseases affecting masticatory muscles and temporomandibular joints (TMJ). In this context, the chronic TMD could be considered as a condition with chronic primary orofacial pain, presenting as myofascial TMD pain or TMJ arthralgia. In this context, myogenous TMD may present overlapping features with other disorders, such as fibromyalgia and primary headaches, characterized by chronic primary pain related to dysfunction of the central nervous system (CNS), probably through the central sensitization. This phenomenon could be defined as an amplified response of the CNS to sensory stimuli and peripheral nociceptive, characterized by hyperexcitability in the dorsal horn neurons in the spinal cord, which ascend through the spinothalamic tract. The main objectives of the management of TMD patients are: decreasing pain, increasing TMJ function, and reducing the reflex masticatory muscle spasm/pain. The first-line treatments are physical therapy, pharmacological drugs, occlusal splints, laser therapy, extracorporeal shockwave therapy, transcutaneous electrical nerve stimulation, and oxygen–ozone therapy. Although all these therapeutic approaches were shown to have a positive impact on the central sensitization of TMD pain, there is still no agreement on this topic in the scientific literature. Thus, in this comprehensive review, we aimed at evaluating the evidence on pain management and rehabilitation for the central sensitization in TMD patients.

Verified
Journal Article
Open access
PDF file
Alessandro de SireAlessandro de Sire
Alessandro de Sire
Nicola MarottaNicola Marotta
Nicola Marotta
Martina FerrilloMartina Ferrillo
Martina Ferrillo
FAFrancesco Agostini
Francesco Agostini
CSCRISTIANO SCONZA
CRISTIANO SCONZA
Ammendolia AntonioAmmendolia Antonio
Ammendolia Antonio
To date, the application of oxygen-ozone (O2O3) therapy has significantly increased in the common clinical practice in several pathological conditions. However, beyond the favorable clinical effects, the biochemical effects of O2O3 are still far from being understood. This comprehensive review aimed at investigating the state of the art about the effects of O2O3 therapy on pro-inflammatory cytokines serum levels as a modulator of oxidative stress in patients with musculoskeletal and temporomandibular disorders (TMD). The efficacy of O2O3 therapy could be related to the moderate oxidative stress modulation produced by the interaction of ozone with biological components. More in detail, O2O3 therapy is widely used as an adjuvant therapeutic option in several pathological conditions characterized by chronic inflammatory processes and immune overactivation. In this context, most musculoskeletal and temporomandibular disorders (TMD) share these two pathophysiological processes. Despite the paucity of in vivo studies, this comprehensive review suggests that O2O3 therapy might reduce serum levels of interleukin 6 in patients with TMD, low back pain, knee osteoarthritis and rheumatic diseases with a concrete and measurable interaction with the inflammatory pathway. However, to date, further studies are needed to clarify the effects of this promising therapy on inflammatory mediators and their clinical implications.

29 July 2022 in Acta Odontologica Scandinavica
Verified
Journal Article
Closed access
Martina FerrilloMartina Ferrillo
Martina Ferrillo
MMMario Migliario
Mario Migliario
NMNicola Marotta
Nicola Marotta
FFFrancesco Fortunato
Francesco Fortunato
MBMarino Bindi
Marino Bindi
Alessandro de SireAlessandro de Sire
Alessandro de Sire
To evaluate the linkage underpinning different clinical conditions as painful TMD and neck pain in patients affected by primary headaches.In this machine learning study, data from medical records o...

15 April 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
Martina FerrilloMartina Ferrillo
Martina Ferrillo
Nicola MarottaNicola Marotta
Nicola Marotta
Amerigo GiudiceAmerigo Giudice
Amerigo Giudice
Dario CalafioreDario Calafiore
Dario Calafiore
CCClaudio Curci
Claudio Curci
Alessandro de SireAlessandro de Sire
Alessandro de Sire
There is still a gap in the scientific knowledge on the linkage between craniofacial structure and spinal postural control in temporomandibular disorder (TMD) patients. This systematic review aimed to assess the role of occlusal splints on spinal posture of TMD patients. PubMed, Web of Science, and Scopus were systematically searched from inception until 5 January 2022 to identify observational studies with a longitudinal study design presenting: patients with diagnosis of TMD according to the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD); occlusal splint therapy as intervention; postural assessment as outcome. Out of 133 records identified, 104 were suitable for data screening, and only 7 articles were included satisfying the eligibility criteria. We found that occlusal splints might have a positive effect on posture in TMD patients, albeit there is little evidence of appropriate investigation for postural assessment. This systematic review suggested that the occlusal splint might be considered a non-invasive therapeutic approach for patients with TMD. However, the low number of studies with high-quality methodology in these patients showed an urgent need for further research using combined force platform stabilometry and kinematic evaluation of the spine to investigate the impact of occlusal splints on posture.

Verified
Journal Article
Open access
PDF file
Martina FerrilloMartina Ferrillo
Martina Ferrillo
Amerigo GiudiceAmerigo Giudice
Amerigo Giudice
MMMario Migliario
Mario Migliario
Filippo RenòFilippo Renò
Filippo Renò
Lorenzo LippiLorenzo Lippi
Lorenzo Lippi
Alessandro de SireAlessandro de Sire
Alessandro de Sire
Periodontal diseases are oral inflammatory diseases affecting the tissues supporting and surrounding the teeth and include gingivitis and periodontitis. Oral pathogens may lead to microbial products spreading into the systemic circulation and reaching distant organs, while periodontal diseases have been related to low-grade systemic inflammation. Gut and oral microbiota alterations might play a role in the pathogenesis of several autoimmune and inflammatory diseases including arthritis, considering the role of the gut–joint axis in the regulation of molecular pathways involved in the pathogenesis of these conditions. In this scenario, it is hypothesized that probiotics might contribute to the oral and intestinal micro-ecological balance and could reduce low-grade inflammation typical of periodontal diseases and arthritis. This literature overview aims to summarize state-of-the-art ideas about linkages among oral–gut microbiota, periodontal diseases, and arthritis, while investigating the role of probiotics as a potential therapeutic intervention for the management of both oral diseases and musculoskeletal disorders.